NICE clears Xarelto for pulmonary embolism

Candace Stuart | | Cardiovascular Business | Pulmonary embolism

The U.K.’s National Institute for Health and Care Excellence (NICE) has recommended the anticoagulant rivaroxaban as a possible treatment for adults with pulmonary embolism and to prevent recurrent deep vein thrombosis or pulmonary embolism.

Rivaroxaban (Xarelto, Janssen Pharmaceuticals/Bayer HealthCare) is a factor Xa inhibitor. In April, NICE issued a draft guidance in favor of rivaroxaban after it determined that the drug was a clinically effective and cost-effective treatment.  

The recommendation, which defined rivaroxaban as “an option,” requires the National Health Service to make it available for use within three months. The guidance may be reviewed in May 2015, according to NICE.

Candace Stuart, Contributor

Related Content

Medical device startup exits stealth mode to name CEO, announce $21M in funding
Pulmonary embolism treatments continue to evolve
REAL-PE highlights disparities in pulmonary embolism care
A cardiologist's guide to treating pulmonary embolism
Interventional cardiology sees growing role in pulmonary embolism interventions
AI dramatically reduces radiologists’ rate of missed incidental pulmonary embolism on routine CT

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup